Myeloma - Best Care in 2026

Myeloma - Best Care in 2026

by Dr Justin Du Toit

Life & Natural Systems Medicine & Health MJCDiseases and disordersMJCLOncology
🎙 Dr Justin Du Toit 👥 2K 📅 May 9, 2026 ⏱ 31 min 👁 96 📄 expert opinion 🧭 2026-08-15
Available in: English (current) Français

Keywords

multiple myelomadiagnosistreatmentautologous transplantcytogenetics

Summary

The presentation covers the pathobiology, epidemiology, diagnosis, and treatment of multiple myeloma, emphasizing the importance of early detection and the role of autologous stem cell transplantation. The speaker explains the two-hit model of pathogenesis, including cytogenetic abnormalities and microenvironment interactions. Epidemiology data from the US shows an incidence of 7 per 100,000, with higher risk in African descent and familial cases. Diagnosis relies on CRAB criteria, but many patients present with non-specific symptoms, leading to delayed diagnosis. A study from UCT highlights missed opportunities, with abnormal lab results often overlooked. Treatment strategies depend on risk stratification based on cytogenetics and staging. For transplant-eligible patients, induction with VRD followed by autologous transplant is standard, with daratumumab added if affordable. For non-eligible patients, VRD with or without daratumumab is used. The autologous transplant process is detailed, including stem cell mobilization, apheresis, cryopreservation, and the conditioning regimen with melphalan. The presentation concludes that while myeloma remains incurable, current treatments offer improved outcomes.

159 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the current state of myeloma care, particularly in the South African context. The speaker effectively argues for increased vigilance in diagnosis, citing a local study showing significant diagnostic delays. The explanation of treatment pathways is clear and evidence-based, referencing randomized trials for transplant. The discussion of practical challenges, such as the cost of daratumumab, adds real-world relevance. The argumentation is solid, though some claims lack specific citations.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor, with references to established criteria (CRAB), staging systems, and treatment protocols. The speaker cites a UCT study and mentions randomized controlled trials for transplant, but does not provide specific references. The title accurately reflects the content, focusing on best care practices. The content is well-structured and technically accurate, though the lack of explicit citations in the slides may limit verifiability.

153 words

Title / Content Match

The title accurately reflects the content, which focuses on current best practices in myeloma care as of 2026.

Quality & Reliability

8/10

Presentation by an experienced clinical hematologist, based on established medical knowledge and recent studies, with clear explanations of mechanisms and treatment protocols. Some statements lack specific citations, but overall reliable.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • Rajkumar et al. (real-world presentations) — Mentioned in the context of typical symptoms at presentation.
  • UCT study on diagnostic delay — Study of 150 patients showing missed opportunities for earlier diagnosis.

Concurring Sources

  • Multiple myeloma - Mayo Clinic — Concordant with the clinical features and treatment approaches discussed.

Contribution & Novelties

The presentation offers a comprehensive overview of myeloma care, with a focus on practical aspects relevant to low- and middle-income settings, such as the cost of novel agents and the feasibility of transplants. It emphasizes the importance of early diagnosis and provides actionable advice for clinicians. The inclusion of a local study on diagnostic delays adds valuable regional context.

Pour aller plus loin :

91 words

Radar Profile

The radar profile shows high scores across all dimensions, indicating a well-rounded presentation with strong information content, technical depth, and reliability. The balance between quantity and quality of information is particularly notable.

Reliability 8/10

💬 No comments were provided for analysis.